FDA Announces Ambitious AI Expansion to Streamline Scientific Reviews
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has unveiled a historic initiative to implement artificial intelligence (AI) technologies agency-wide, with a target completion date of June 30, …
FDA Announces Ambitious AI Expansion to Streamline Scientific Reviews Read More